Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on June 16, 2008

Cardiovascular Research, doi:10.1093/cvr/cvn163
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
80/1/40    most recent
cvn163v2
cvn163v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kitahara, T.
Right arrow Articles by Kubota, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitahara, T.
Right arrow Articles by Kubota, I.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice

Tatsuro Kitahara, M.D.1, Yasuchika Takeishi, M.D.3, Mutsuo Harada, M.D.1, Takeshi Niizeki, M.D.1, Satoshi Suzuki, M.D.1, Toshiki Sasaki, M.D.1, Mitsunori Ishino, M.D.1, Olga Bilim, M.D.1, Osamu Nakajima, Ph.D.2 and Isao Kubota, M.D.1

1 Department of Cardiology, Pulmonology and Nephrology
2 Research Laboratory for Molecular Genetics, Yamagata University School of Medicine, Yamagata
3 First Department of Internal Medicine, Fukushima Medical University, Fukushima, Japan

Address for reprints: Yasuchika Takeishi, M.D. First Department of Internal Medicine Fukushima Medical University 1 Hikarigaoka, Fukushima, Japan 960-1295 E-mail: takeishi{at}fmu.ac.jp Phone: +81-24-547-1188 Fax: +81-24-548-1821

Aim: High-mobility group box 1 (HMGB1) is a nuclear DNA-binding protein and is released from necrotic cells, inducing inflammatory responses and promoting tissue repair and angiogenesis. To test the hypothesis that HMGB1 enhances angiogenesis and restores cardiac function after myocardial infarction, we generated transgenic mice with cardiac-specific overexpression of HMGB1 (HMGB1-Tg) using {alpha}-myosin heavy chain (MHC) promoter.

Methods and Results: The left anterior descending coronary artery was ligated in HMGB1-Tg and wild-type littermate (Wt) mice. After coronary artery ligation, HMGB1 was released into circulation from the necrotic cardiomyocytes of HMGB1-overexpressing hearts. The size of myocardial infarction was smaller in HMGB1-Tg than in Wt mice. Echocardiography and cardiac catheterization demonstrated that cardiac remodeling and dysfunction after myocardial infarction were prevented in HMGB1-Tg mice compared to Wt mice. Furthermore, the survival rate after myocardial infarction of HMGB1-Tg mice was higher than that of Wt mice. Immunohistochemical staining revealed that capillary and arteriole formation after myocardial infarction was enhanced in HMGB1-Tg mice.

Conclusions: We report the first in vivo evidence that HMGB1 enhances angiogenesis, restores cardiac function, and improves survival after myocardial infarction. These results may provide a novel therapeutic approach for left ventricular dysfunction after myocardial infarction.

KEYWORDS HMGB1; cardiac remodeling; myocardial infarction; angiogenesis


Time for primary review: 20 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

High-mobility group box 1 protein (HMGB1) in ischaemic heart disease: beneficial or deleterious?
Masafumi Takahashi
Cardiovasc Res 2008 80: 5-6. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Kohno, T. Anzai, K. Naito, T. Miyasho, M. Okamoto, H. Yokota, S. Yamada, Y. Maekawa, T. Takahashi, T. Yoshikawa, et al.
Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling
Cardiovasc Res, February 15, 2009; 81(3): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Takahashi
High-mobility group box 1 protein (HMGB1) in ischaemic heart disease: beneficial or deleterious?
Cardiovasc Res, October 1, 2008; 80(1): 5 - 6.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.